> Chutes & Ladders: Clinical Data has selected Drew Fromkim as its new CEO and decided to spin off its antidepressant business. Report
> Wockhardt has been given FDA approval to market a generic version of Hoffman La Roche's Rocephin injection. Report
> Alexion Pharmaceuticals says that preclinical models indicate the effectiveness of its experimental therapy for acute severe allergic asthma. Report
> Advaxis has developed an additional vaccine for ovarian cancer, Lovaxin S. Release
> A new trial has underscored Crestor's effectiveness in reducing cholesterol in high-risk patients. Release
And Finally... There's more encouraging news on the avian flu front. Two of the hardest hit Asian countries, Thailand and Vietnam, have gone for a lengthy stretch without any new human or bird cases, raising hopes that the virus can be snuffed out. Article